The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.24BCNY
629.85M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
437.19MCNY
64.93M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
-41.00%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Beta
0.8170x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-32.26%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
4.24BCNY
629.85M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
3.58BCNY
531.74M · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
20.24x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Price to Sales (TTM)
10.71x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 9.7×.Updated Aug 19, 2026
Price to Book (MRQ)
2.87x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Enterprise to Revenue
8.19x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Enterprise to EBITDA
-51.38x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 450.75×.Updated Aug 19, 2026
Gross Margin
30.32%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Profit Margin
-41.00%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Operating Margin
-9.64%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Return on Assets (TTM)
-2.38%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Return on Equity (TTM)
-11.44%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Revenue (TTM)
437.19MCNY
64.93M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
2.16CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
-1.70%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Gross Profit (TTM)
128.05MCNY
19.02M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
7.94MCNY
1.18M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
-179.23MCNY
-26.62M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-6.94%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
32.42MCNY
4.81M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
40.12MCNY
5.96M · vs all stocks (USD)
Updated Aug 19, 2026
5-Year Average Dividend Yield
0.38%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Minority Interest (Equity)
16.18MCNYFY2025 · Dec 31, 2025
Revenue
439.09MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
302.87MCNYFY2025 · Dec 31, 2025
Gross Profit
136.22MCNYFY2025 · Dec 31, 2025
Operating Income
-70.31MCNY
-10.44M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-199.61MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.58MCNYFY2025 · Dec 31, 2025
Net Income
-198.03MCNYFY2025 · Dec 31, 2025
EBIT
-194.45MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
7.94MCNYFY2025 · Dec 31, 2025
Research & Development
29.80MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
47.52MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.99MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
10.39MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.15MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.8800CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.8800CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
202.38MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
202.38MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-198.03MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
19.94MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-195.36MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-220.14MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
640.47MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-198.03MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
11.11MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
51.88MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-60.31MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-24.78MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-644.50KCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.31BCNYFY2025 · Dec 31, 2025
Sale of Investments
2.07BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-876.07KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-264.74MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
10.33MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-354.29KCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-166.52KCNYFY2025 · Dec 31, 2025
Other Financing Charges
-40.97MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-31.16MCNYFY2025 · Dec 31, 2025
Shares Outstanding
228.99MSharesUpdated Aug 19, 2026
Float Shares
176.68MSharesUpdated Aug 19, 2026
% Held by Insiders
32.30%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
1.31%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
1.24BCNY
183.49M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
5.47CNYUpdated Aug 19, 2026
Total Debt (MRQ)
140.86MCNY
20.92M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.0867x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Current Ratio (MRQ)
3.23x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
7.13CNYUpdated Aug 19, 2026
Total Assets
2.35BCNY
348.30M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.72BCNYFY2025 · Dec 31, 2025
Total Liabilities
714.62MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
627.95MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
143.43MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
571.19MCNYFY2025 · Dec 31, 2025
Cash
639.44MCNYFY2025 · Dec 31, 2025
Cash Equivalents
32.38MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
671.82MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
616.35MCNYFY2025 · Dec 31, 2025
Accounts Receivable
68.25MCNYFY2025 · Dec 31, 2025
Inventory
288.89MCNYFY2025 · Dec 31, 2025
Accounts Payable
177.16MCNYFY2025 · Dec 31, 2025
Short-term Debt
44.46MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
28.07MCNYFY2025 · Dec 31, 2025
Long-term Debt
103.75MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
228.99MCNYFY2025 · Dec 31, 2025
Retained Earnings
93.01MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.63BCNY
242.16M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
40.09MCNYFY2025 · Dec 31, 2025
52-Week Low
14.34CNYUpdated Aug 19, 2026
52-Week High
36.79CNYUpdated Aug 19, 2026
52-Week Change
-32.26%
vs all stocks
Updated Aug 19, 2026
Beta
0.8170x
vs all stocks
Updated Aug 19, 2026
50-Day MA
22.66CNYUpdated Aug 19, 2026
200-Day MA
27.39CNYUpdated Aug 19, 2026
Avg 10-Day Volume
4.41MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
6.31MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-0.8900CNYUpdated Aug 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.